Folate and Homocysteine Metabolism: Therapeutic Targets in Cardiovascular and Neurodegenerative Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|10|19|1923-1929

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.19, 2003-10, pp. : 1923-1929

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders

By  

Current Pharmaceutical Design, Vol. 19, Iss. 28, 2013-04 ,pp. : 5051-5064

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs Affecting Homocysteine Metabolism: Impact on Cardiovascular Risk

By Desouza C.   Keebler M.   McNamara D.B.   Fonseca V.  

Drugs, Vol. 62, Iss. 4, 2002-04 ,pp. : 605-616

Adis International

Access to resources Recommend Favorite

Homocysteine: A Risk Factor in Patietns with Cardiovascular Disorders in Pakistan

By  

Current Bioactive Compounds, Vol. 11, Iss. 4, 2015-12 ,pp. : 210-214

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptides as Therapeutic Targets in Anxiety Disorders

By  

Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. : 5709-5727

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Efficacy of Selegiline in Neurodegenerative Disorders and Neurological Diseases

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1513-1529

Bentham Science Publishers

Access to resources Recommend Favorite